Status:
TERMINATED
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
Lead Sponsor:
New Mexico Cancer Research Alliance
Collaborating Sponsors:
The Feminist Majority Foundation
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to see if mifepristone prevents worsening of your cancer. Mifepristone is an antiprogesterone agent, a drug which blocks female hormones, that is commonly used for the ter...
Detailed Description
This is a compassionate use of mifepristone treatment for patients with conditions that could respond to an antiprogesterone agent, including: * Meningioma. * Breast cancer * Colon Cancer * Endometri...
Eligibility Criteria
Inclusion
- All patients 18 years of age or older.
- Patients must sign an informed consent.
- Patients should be in such a health condition in the opinion of the attending physician that with the administration of mifepristone benefits may outweigh risks.
Exclusion
- Pregnant women or nursing mothers are not eligible for this trial. Patients of child bearing potential must use adequate contraception.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00832871
Start Date
November 1 2008
End Date
December 1 2015
Last Update
June 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universtiy of New Mexico - Cancer Center
Albuquerque, New Mexico, United States, 87106